FDA Inspection 1088641 — Triangle Compounding Pharmacy Inc
The FDA completed an inspection of Triangle Compounding Pharmacy Inc on April 4, 2019 in Cary, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 4, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cary, NC (United States)